相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metformin use and prostate cancer risk A meta-analysis of cohort studies
Zhaohan Feng et al.
MEDICINE (2019)
Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients
Rashid K. Sayyid et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
Joseph Longo et al.
MOLECULAR METABOLISM (2019)
Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study
Oskar O. E. Halfdanarson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
The anticancer potential of metformin on prostate cancer
Saher Zaidi et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis
Kancheng He et al.
SCIENTIFIC REPORTS (2019)
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Kerri Beckmann et al.
JAMA NETWORK OPEN (2019)
Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy
Kyle A. Richards et al.
JOURNAL OF UROLOGY (2018)
Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial
Patrick Lewicki et al.
JOURNAL OF UROLOGY (2017)
Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008
Jee Soo Park et al.
MEDICINE (2017)
Metformin and Prostate Cancer: a New Role for an Old Drug
Jessica Whitburn et al.
CURRENT UROLOGY REPORTS (2017)
Lifetime risk of diabetes among First Nations and non-First Nations people
Tanvir Chowdhury Turin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells
Nicole M. A. White-Al Habeeb et al.
PROSTATE (2016)
Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort
Bimal Bhindi et al.
EUROPEAN UROLOGY (2015)
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
Eric I. Benchimol et al.
PLOS MEDICINE (2015)
Metformin Use and Prostate Cancer Risk
Mark A. Preston et al.
EUROPEAN UROLOGY (2014)
Metformin targets c-MYC oncogene to prevent prostate cancer
Tunde Akinyeke et al.
CARCINOGENESIS (2013)
Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
Daniel E. Spratt et al.
EUROPEAN UROLOGY (2013)
Metformin Use and All-Cause and Prostate Cancer-Specific Mortality Among Men With Diabetes
David Margel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Association Between Metformin Use and Risk of Prostate Cancer and Its Grade
David Margel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
When do we need competing risks methods for survival analysis in nephrology?
Marlies Noordzij et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Synergistic killing effect of chloroquine and androgen deprivation in LNCaP cells
Ramesh R. Kaini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
T. Tomic et al.
CELL DEATH & DISEASE (2011)
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Michael Pollak
CANCER PREVENTION RESEARCH (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
T. J. Murtola et al.
BRITISH JOURNAL OF CANCER (2009)
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Science, medicine, and the future - Cancer chemoprevention
P Greenwald
BMJ-BRITISH MEDICAL JOURNAL (2002)